SPL MEDGUIDE SECTION
Manufactured by:
Cadila Heathcare Ltd.
India
Manufactured by:
Cadila Heathcare Ltd.
India
| Class | Version | Type | Effective |
|---|---|---|---|
| GABAPENTIN Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20230427 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| cdc2ae60-922e-452d-a42f-787fe4e2ed06 | Product name | 1 | 20250123 |
| 7059096a-4b9f-36c2-db50-bb5c723e6e9e | Product name | 2 | 20250114 |
| fa3f0129-3502-889f-f424-3a37727959e7 | Product name | 9 | 20181206 |
| 77d89e4c-f57f-326d-d7aa-787f8eebbd2b | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65841-705-01 | Gabapentin | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 8 | |
| 65841-705-05 | Gabapentin | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 8 | |
| 65841-705-10 | Gabapentin | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 8 | |
| 65841-706-01 | Gabapentin | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 8 | |
| 65841-706-05 | Gabapentin | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 8 | |
| 65841-706-10 | Gabapentin | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 8 | |
| 65841-706-77 | Gabapentin | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 8 | |
| 65841-706-77 | Gabapentin | 10 in 1 CARTON | TABLET, FILM COATED | 10 | 8 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 65841-705 | GABAPENTIN TABLET, FILM COATED [ZYDUS LIFESCIENCES LIMITED] | 8 | Current NDC, Legacy NDC, 3 package rows | 20241201_b033c169-4943-4ad9-ace0-7e4a1f0dc100.zip |
| 65841-706 | GABAPENTIN TABLET, FILM COATED [ZYDUS LIFESCIENCES LIMITED] | 8 | Current NDC, Legacy NDC, 5 package rows | 20241201_b033c169-4943-4ad9-ace0-7e4a1f0dc100.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| GABAPENTIN | ACTIVE INGREDIENT | 6CW7F3G59X | 1 | |
| GABAPENTIN | ACTIVE MOIETY | 6CW7F3G59X | 1 | |
| COPOVIDONE | INACTIVE INGREDIENT | D9C330MD8B | 1 | |
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | INACTIVE INGREDIENT | 2165RE0K14 | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | 1 | |
| POLOXAMER 407 | INACTIVE INGREDIENT | TUF2IVW3M2 | 1 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 65841-705 | 65841-705-01, 65841-705-05, 65841-705-10 |
| 65841-706 | 65841-706-01, 65841-706-05, 65841-706-10, 65841-706-77 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GABAPENTIN | 6CW7F3G59X | ACTIB |
| COPOVIDONE K25-31 | D9C330MD8B | IACT |
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | 2165RE0K14 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MANNITOL | 3OWL53L36A | IACT |
| POLOXAMER 407 | TUF2IVW3M2 | IACT |
| POVIDONE | FZ989GH94E | IACT |
| TALC | 7SEV7J4R1U | IACT |
| GABAPENTIN | 6CW7F3G59X | ACTIB |
| COPOVIDONE K25-31 | D9C330MD8B | IACT |
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | 2165RE0K14 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MANNITOL | 3OWL53L36A | IACT |
| POLOXAMER 407 | TUF2IVW3M2 | IACT |
| POVIDONE | FZ989GH94E | IACT |
| TALC | 7SEV7J4R1U | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE, EXTENDED RELEASE / ORAL | 40 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE, DELAYED RELEASE / ORAL | 5 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | TABLET, FILM COATED / ORAL | 2309 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | TABLET, FILM COATED / ORAL | 2309 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | SUSPENSION / ORAL | 10 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | POWDER, FOR SUSPENSION / ORAL | 0.01 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE, DELAYED RELEASE / ORAL | 5 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | SOLUTION / ORAL | 50 mg/5ml | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | SOLUTION / ORAL | 50 mg/5ml | ||
| COPOVIDONE | COPOVIDONE K25-31 | D9C330MD8B | TABLET, FILM COATED / ORAL | 5917 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | SOLUTION / ORAL | 50 mg/5ml | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | SUSPENSION / ORAL | 10 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, FILM COATED / ORAL | 40 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE, DELAYED RELEASE / ORAL | 5 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE, EXTENDED RELEASE / ORAL | 40 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| COPOVIDONE | COPOVIDONE K25-31 | D9C330MD8B | TABLET, FILM COATED / ORAL | 5917 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE / ORAL | 468 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | POWDER, FOR SUSPENSION / ORAL | 0.01 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | SOLUTION / ORAL | 50 mg/5ml | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE, EXTENDED RELEASE / ORAL | 40 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE, EXTENDED RELEASE / ORAL | 40 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE, EXTENDED RELEASE / ORAL | 40 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, FILM COATED / ORAL | 40 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE / ORAL | 468 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE / ORAL | 468 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE / ORAL | 468 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE, EXTENDED RELEASE / ORAL | 40 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, FILM COATED / ORAL | 40 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | POWDER, FOR SUSPENSION / ORAL | 0.01 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | SUSPENSION / ORAL | 10 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, FILM COATED / ORAL | 40 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, FILM COATED / ORAL | 40 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE, EXTENDED RELEASE / ORAL | 40 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE, DELAYED RELEASE / ORAL | 5 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, FILM COATED / ORAL | 40 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | TABLET, FILM COATED / ORAL | 2309 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | POWDER, FOR SUSPENSION / ORAL | 0.01 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, FILM COATED / ORAL | 40 mg | ||
| COPOVIDONE | COPOVIDONE K25-31 | D9C330MD8B | TABLET, FILM COATED / ORAL | 5917 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE, DELAYED RELEASE / ORAL | 5 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | POWDER, FOR SUSPENSION / ORAL | 0.01 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | SOLUTION / ORAL | 50 mg/5ml | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | TABLET / ORAL | 495 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | SUSPENSION / ORAL | 10 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | POWDER, FOR SUSPENSION / ORAL | 0.01 mg | ||
| POLOXAMER 407 | POLOXAMER 407 | TUF2IVW3M2 | TABLET / ORAL | 495 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078926-001 | GABAPENTIN | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | |
| A078926-002 | GABAPENTIN | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 |
| Application-product | TE code |
|---|---|
| A078926-001 | AB1 |
| A078926-002 | AB1 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2011-02-11 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2011-02-11 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB | 2011-02-11 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB | 2011-02-11 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB | 2011-02-11 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB | 2011-02-11 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A078926-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB | 2011-02-11 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A078926-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB | 2011-02-11 | 4b0b4de00fa7… |
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A078926-001 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A078926-002 | AB1 | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A078926-001 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A078926-002 | AB1 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A078926-001 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A078926-002 | AB1 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A078926-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A078926-002 | AB1 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078926-001 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078926-002 | AB1 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A078926-001 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A078926-002 | AB1 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078926-001 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078926-002 | AB1 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078926-001 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078926-002 | AB1 | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078926-001 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078926-002 | AB1 | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078926-001 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078926-002 | AB1 | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078926-001 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078926-002 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078926-001 | AB1 | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078926-002 | AB1 | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A078926-001 | AB1 | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A078926-002 | AB1 | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078926-001 | AB1 | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078926-002 | AB1 | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078926-001 | AB1 | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078926-002 | AB1 | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078926-001 | AB1 | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A078926-002 | AB1 | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A078926-001 | AB1 | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A078926-002 | AB1 | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078926-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A078926-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A078926-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A078926-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A078926-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A078926-002 | AB | 1 | 4b0b4de00fa7… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Zydus Lifesciences Limited | b033c169-4943-4ad9-ace0-7e4a1f0dc100 | 2024-11-30 | 65841-706-77 65841-706-01 65841-705-10 65841-705-01 65841-706-10 65841-706-05 65841-705-05 65841-705 65841-706 65841070601 65841070501 65841070610 65841070605 65841070505 65841070677 65841070510 e9f9a5e6-0454-4601-90e4-b170bb325eb6 b033c169-4943-4ad9-ace0-7e4a1f0dc100 |
Adverse event summaries are temporarily unavailable. Other product information remains available.